Carlsmed，一家专注于人工智能个性化手术医疗科技的公司，近日宣布成功完成5250万美元的C轮融资。本轮融资由B Capital和US Venture Partners共同领投，资金将用于推动其腰椎融合手术的aprevo®个性化脊柱手术平台的市场化，并加快颈椎融合手术用aprevo®的开发，预计将于2025年面世。
Carlsmed的aprevo®平台利用人工智能技术，为每位患者提供个性化手术解决方案，显著提高了手术效果和康复速度。这一创新科技在医疗领域的应用前景广阔，受到了投资者的广泛关注。
此次融资的成功，不仅体现了市场对Carlsmed技术和团队的高度认可，也为公司未来的发展奠定了坚实的基础。随着融资的完成，Carlsmed将进一步扩大研发和市场团队，以满足不断增长的市场需求。
英文标题：Carlsmed Raises $52.5 Million in Series C Funding to Accelerate Commercialization of its Personalized Spine Surgery Platform
英文关键词：AI-powered personalized spine surgery, funding round, product development
英文新闻内容：Carlsmed, an artificial intelligence (AI)-driven personalized surgery technology company, recently announced the successful completion of a $52.5 million Series C funding round. The investment, led by B Capital and US Venture Partners, will be used to accelerate the commercialization of its aprevo® personalized spine surgery platform for lumbar fusion surgeries and to expedite the development of the aprevo® platform for cervical fusion surgeries, which is expected to launch in 2025.
The aprevo® platform utilizes AI to provide personalized surgical solutions for each patient, significantly improving surgical outcomes and recovery times. The innovative application of AI in the healthcare sector has garnered significant attention from investors, highlighting the potential of Carlsmed’s technology and team.
The completion of this funding round not only validates the market’s recognition of Carlsmed’s technology and team but also lays a solid foundation for the company’s future growth. With the funding secured, Carlsmed plans to expand its research and development and market teams to meet the growing market demand.
【来源】https://www.businesswire.com/news/home/20240318820510/en/Carlsmed-Raises-52.5M-in-Series-C-Financing-to-Advance-Personalized-Spine-Surgery
Views: 1